Earlier this month, I shared with you a quote from Arnoud Balhuizen, chief commercial officer of BHP Billiton, the largest mining company in the world. In a September interview with Reuters, Balhuizen called 2017 the “revolution year [for electric vehicles], and copper
November 28, 2017
Hasbro (HAS) is not playing around. One of the largest companies in the toy industry is looking to acquire major competitor Mattel (MAT) according to a report from The Wall Street Journal . Mattel reportedly rejected Hasbro’s first offer, but I could
While the prevailing outlook by the big banks for 2018 and onward has been predominantly optimistic and in a few euphoric cases, “rationally exuberant”, with most banks forecasting year-end S&P price targets around 2800 or higher, and a P/E of
Written by eVestment The continued positive aggregate returns to start Q4 lifted hedge fund assets to another all-time high, despite net flows in negative territory for a second consecutive month. On a net basis, outflows were small again in October, but the industry
Wholesale and retail inventories both declined in October according to the Census Bureau Advance Indicators report. Census Bureau Advance Inventory Numbers Chart excerpted from the Census Bureau Advance Indicators report. The inventory numbers are likely to reduce fourth-quarter GDP estimates slightly.
Top tickers for end of day: BAC, F, AAPL, ZNGA.
Today the Richmond Fed Manufacturing Composite Index was at 30 for the month of November, up from last month’s 12. Investing.com had forecast 14. Because of the highly volatile nature of this index, we include a 3-month moving average to facilitate the
The Chart of the Day belongs to Valhi (VHI). Since the Trend Spotter signaled a buy in 10/2 the stock gained 140.45%. Valhi Inc. operates through majority-owned subsidiaries or less than majority-owned affiliates in the chemicals, component products, waste management and titanium metals industries.
After the drug pricing issue crippled its performance last year, the drug/biotech industry, except for a small correction recently, has witnessed a turnaround this year. Stocks with large market cap have done particularly well. After declining 5.2% last year, the Large
After the drug pricing issue crippled its performance last year, the drug/biotech industry, except for a small correction recently, has witnessed a turnaround this year. Stocks with large market cap have done particularly well. After declining 5.2% last year, the Large
